orforglipron and retatrutide 6mg GLP1-O (90 Capsules) New Kind of Diabetes Drug

Patients are evolving

it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak

GLP-1 drugs have been used by large shares of adults who say they have been diagnosed with diabetes (57% have ever used the drug, including 45% who are currently using), heart disease (40% ever, 29% currently), or as obese or overweight in the past five years (34% ever, 23% currently)

10.1053/j.gastro.2024.04.029 82 WeiS.WangL.EvansP

Convenient Dosing: Ozempics once-weekly injection schedule improves treatment adherence by simplifying the regimen, making it easier for our patients to incorporate into their lifestyles compared to the multiple daily injections required with traditional insulin therapy